Revised FIGO staging for carcinoma of the vulva
2009; Elsevier BV; Volume: 105; Issue: 2 Linguagem: Inglês
10.1016/j.ijgo.2009.02.011
ISSN1879-3479
Autores Tópico(s)Cervical Cancer and HPV Research
ResumoInternational Journal of Gynecology & ObstetricsVolume 105, Issue 2 p. 105-106 Special communications Revised FIGO staging for carcinoma of the vulva Neville F. Hacker, Corresponding Author Neville F. Hacker [email protected] Royal Hospital for Women and University of New South Wales, Sydney, AustraliaSearch for more papers by this author Neville F. Hacker, Corresponding Author Neville F. Hacker [email protected] Royal Hospital for Women and University of New South Wales, Sydney, AustraliaSearch for more papers by this author First published: 28 March 2009 https://doi.org/10.1016/j.ijgo.2009.02.011Citations: 96Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References [1]Hacker N.F. Vulvar Cancer J.S. Berek, N.F. Hacker. Practical Gynecologic Oncology. 4th edition. 2005; Lippincott, Williams and Wilkins: Philadelphia; 543–581 [2]Homesley H.D., Bundy B.N., Sedlis A., Yordan E., Berek J.S., Jahshan A., et al. Assessment of current International Federation of Gynecology and Obstetrics staging of vulvar carcinoma relative to prognostic factors for survival (a Gynecologic Oncology Group study). Am J Obstet Gynecol. 164, (4): 1991; 997–1004 [3]Hacker N.F., Berek J.S., Lagasse L.D., Leuchter R.S., Moore J.G. Management of regional lymph nodes and their prognostic influence in vulvar cancer. Obstet Gynecol. 61, (4): 1983; 408–412 [4]Hoffman J.S., Kumar N.B., Morley G.W. Prognostic significance of groin lymph node metastases in squamous carcinoma of the vulva. Obstet Gynecol. 66, (3): 1985; 402–405 [5]Morley G.W. Infiltrative carcinoma of the vulva: results of surgical treatment. Am J Obstet Gynecol. 124, (8): 1976; 874–888 [6]Cavanagh D., Roberts W.S., Bryson S.C., Marsden D.E., Ingram J.M., Anderson W.R. Changing trends in the surgical treatment of invasive carcinoma of the vulva. Surg Gynecol Obstet. 162, (2): 1986; 164–168 [7]Unpublished SEER data. Courtesy of P DiSaia. [8]Tantipalakorn C, Robertson G, Marsden DE, Gebski V, Hacker NF. Outcome and patterns of recurrence for FIGO stages I and II squamous cell vulvar cancer. Obstet Gynecol. 2009;113. In Press. [9]Origoni M., Sideri M., Garsia S., Carinelli S.G., Ferrari A.G. Prognostic value of pathological patterns of lymph node positivity in squamous cell carcinoma of the vulva stage III and IVA FIGO. Gynecol Oncol. 45, (3): 1992; 313–316 [10]Paladini D., Cross P., Lopes A., Monaghan J.M. Prognostic significance of lymph node variables in squamous cell carcinoma of the vulva. Cancer. 74, (9): 1994; 2491–2496 [11]van der Velden J., van Lindert A.C., Lammes F.B., ten Kate F.J., Sie-Go D.M., Oosting H., et al. Extracapsular growth of lymph node metastases in squamous cell carcinoma of the vulva. Cancer. 75, (12): 1995; 2885–2890 [12]Hopkins M.P., Reid G.C., Johnston C.M., Morley G.W. A comparison of staging systems for squamous cell carcinoma of the vulva. Gynecol Oncol. 47, (1): 1992; 34–37 [13]Raspagliesi F., Hanozet F., Ditto A., Solima E., Zanaboni F., Vecchione F., et al. Clinical and pathologic prognostic factors in squamous cell carcinoma of the vulva. Gynecol Oncol. 102, (2): 2006; 333–337 [14]Lataifeh I., Nascimento M.C., Nicklin J.L., Perrin L.C., Crandon A.J., Obermair A. Patterns of recurrence and disease-free survival in advanced squamous cell carcinoma of the vulva. Gynecol Oncol. 95, (3): 2004; 701–705 [15]Burger M.P., Hollema H., Emanuels A.G., Krans M., Pras E., Bouma J. The importance of the groin node status for the survival of T1 and T2 vulval carcinoma patients. Gynecol Oncol. 57, (3): 1995; 327–334 [16]Fons G, Hyde SE, Buist M, Schilthuis MS, Grant P, Burger MP, et al. The presence of bilateral positive lymph nodes in squamous cell cancer of the vulva is not an independent prognostic variable for disease – specific survival. Int J Gynecol Cancer. In Press. [17]Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynecol Obstet. 105, (2): 2009; 103–104 Citing Literature Volume105, Issue2May 2009Pages 105-106 ReferencesRelatedInformation
Referência(s)